Quarterly net revenues were RMB1,000.5million (US$143.1 million)1 ...
Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to announce that its IdentiClone Dx IGH Assay has received In Vitro Diagnostic Regulation ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果